| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |